CD19 and lymphoma: Notably, this CRS model was characterized by severe toxicity, with all mice dying in the first 7 days after CAR.CD19-T cell infusion, without the potentially confounding signs of sufferance due to lymphoma cell expansion, since the mice were engrafted with irradiated not-proliferating lymphoma cells (Fig. 6f).